<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26388" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Osteogenesis Imperfecta</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Subramanian</surname>
            <given-names>Surabhi</given-names>
          </name>
          <aff>IWK Health Centre</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Anastasopoulou</surname>
            <given-names>Catherine</given-names>
          </name>
          <aff>Jefferson Einstein Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Viswanathan</surname>
            <given-names>Vibhu Krishnan</given-names>
          </name>
          <aff>IWK Health Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Surabhi Subramanian declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Catherine Anastasopoulou declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Vibhu Krishnan Viswanathan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>6</day>
          <month>2</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26388.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Osteogenesis imperfecta (OI) is a genetic disorder of connective tissues caused by an abnormality in the synthesis or processing of type I collagen. It is also called brittle bone disease. It is characterized by an increased susceptibility to bone fractures and decreased bone density. Other manifestations include blue sclerae, dentinogenesis imperfecta, short stature, as well as deafness in adulthood. There are also reports of valvular insufficiencies and aortic root dilation. Milder manifestations include generalized laxity, easy bruising, hernias, and excess sweating. Clinical manifestations range from mild with a nearly asymptomatic form to most severe forms (involving infants presenting with crumpled ribs, fragile cranium, and long bone fractures incompatible with life), resulting in increased perinatal mortality.[ This activity reviews the pathophysiology of osteogenesis imperfecta and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of osteogenesis imperfecta.</p></list-item><list-item><p>Review the presentation of a patient with osteogenesis imperfecta.</p></list-item><list-item><p>Outline the management options available for osteogenesis imperfecta.</p></list-item><list-item><p>Describe some interprofessional team strategies for improving care coordination and outcomes in patients with osteogenesis imperfecta.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26388&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26388">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26388.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Osteogenesis imperfecta&#x000a0;(OI) is a genetic&#x000a0;disorder of connective tissues caused by an abnormality in the synthesis or processing of type I collagen.<xref ref-type="bibr" rid="article-26388.r1">[1]</xref><xref ref-type="bibr" rid="article-26388.r2">[2]</xref> It is also called brittle bone disease. It is characterized by an increased susceptibility to bone fractures and decreased bone density. Other manifestations include blue sclerae, dentinogenesis imperfecta, short stature, as well&#x000a0;as deafness in adulthood. There are also reports of valvular insufficiencies and aortic root dilation. Milder manifestations include generalized laxity, easy bruising, hernias, and excess sweating.<xref ref-type="bibr" rid="article-26388.r3">[3]</xref> Clinical manifestations range&#x000a0;from&#x000a0;mild with a nearly asymptomatic form to most severe&#x000a0;forms (involving infants presenting with crumpled ribs, fragile cranium, and long bone fractures incompatible with life), resulting in increased perinatal mortality.<xref ref-type="bibr" rid="article-26388.r4">[4]</xref></p>
      </sec>
      <sec id="article-26388.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Osteogenesis imperfecta is a rare genetic disease. In the majority of cases, it occurs secondary to mutations in the&#x000a0;<italic toggle="yes">COL1A1</italic>&#x000a0;and&#x000a0;<italic toggle="yes">COL1A2</italic> genes.&#x000a0;More recently, diverse mutations related to OI have been identified.<xref ref-type="bibr" rid="article-26388.r5">[5]</xref></p>
        <p>The following is the OI classification according to the International Society of Skeletal Dysplasias based on the mode of inheritance and genes involved.<xref ref-type="bibr" rid="article-26388.r6">[6]</xref>&#x000a0;</p>
        <p>
<bold>Osteogenesis Imperfecta / Type / Inheritance / Genes</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Nondeforming OI (Type I) / AD /&#x000a0;<italic toggle="yes">COL1A1, COL1A2 /&#x000a0;</italic>X-linked /&#x000a0;<italic toggle="yes">PLS3</italic></p>
          </list-item>
          <list-item>
            <p>Perinatal (type II) / AD, AR /&#x000a0;<italic toggle="yes">COL1A1, COL1A2, CRTAP, LEPRE1, PPIB, BMP1</italic>&#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Progressively deforming (type III) / AD, AR /&#x000a0;<italic toggle="yes">COL1A1, COL1A2, CRTAP, LEPRE1, PPIB, FKBP10, SERPINH1, SERINF1, WNT1</italic></p>
          </list-item>
          <list-item>
            <p>Moderate (type IV) / AD, AR /&#x000a0;<italic toggle="yes">COL1A1, COL1A2, CRTAP, FKBP10, SP7, SERPINF1, WNT1, TMEM38B</italic></p>
          </list-item>
          <list-item>
            <p>Calcification of interosseous&#x000a0;membrane or hypertrophic callus (type V) / AD /&#x000a0;<italic toggle="yes">IFITM5</italic></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26388.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Osteogenesis imperfecta is a rare disease occurring in 1 in 15,000 to 20,000 births.<xref ref-type="bibr" rid="article-26388.r4">[4]</xref> The population frequencies of type I OI have been reported to range between 2.35 to 4.7 in 100,000 worldwide. Reports of the incidence of type II OI range between 1 in 40,000 to 1.4 in 100,000 live births. The exact incidence of types III and IV OI is not known, although their incidence is much less common than type I.<xref ref-type="bibr" rid="article-26388.r7">[7]</xref><xref ref-type="bibr" rid="article-26388.r8">[8]</xref><xref ref-type="bibr" rid="article-26388.r9">[9]</xref></p>
        <p>In Shapiro's study,&#x000a0;the incidence of types congenita A, congenita B, tarda A, and tarda B was approximately 19%, 31%, 25%, and 25%, respectively.<xref ref-type="bibr" rid="article-26388.r10">[10]</xref><xref ref-type="bibr" rid="article-26388.r11">[11]</xref></p>
      </sec>
      <sec id="article-26388.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Two pro-alpha-1 chains and one pro-alpha-2 chain make up type I collagen, which forms the main protein of the extracellular membrane of skin, bones, tendons, etc., and create a rigid, triple helix structure. Each alpha chain consists of an amino-terminal&#x000a0;pro-peptide, carboxyl-terminal pro-peptide, and a central pro-peptide consisting of&#x000a0;338 glycine repeats. Glycine is the smallest residue that can occupy the axial position of the triple helix.<xref ref-type="bibr" rid="article-26388.r12">[12]</xref>&#x000a0;The triple helix structure of type I collagen is possible because of the presence of glycine at every third amino acid residue.&#x000a0;</p>
        <p>At least 90% of OI patients&#x000a0;have a&#x000a0;genetic defect resulting in&#x000a0;quantitative and qualitative (or both) abnormalities in type I collagen molecules. This disorder is inherited in an autosomal dominant, autosomal recessive, or spontaneous mutation pattern.<xref ref-type="bibr" rid="article-26388.r12">[12]</xref><xref ref-type="bibr" rid="article-26388.r13">[13]</xref> The autosomal dominant forms are caused by&#x000a0;direct&#x000a0;defects in type 1 collagen, while autosomal recessive forms are caused by non-collagenous proteins, which take part in post-translational modifications or triple helix formation.<xref ref-type="bibr" rid="article-26388.r4">[4]</xref></p>
        <p>
<bold>Defects Involving Type 1 Collagen Molecules&#x000a0;</bold>
</p>
        <p>Frameshift mutations (involving premature stop codon in the affected allele) can result in a quantitative decrease in the amount of structurally normal type 1 collagen. Patients who are heterozygous for this condition may secrete half the normal amount of type 1 collagen [haplo-insufficiency, as seen in type IA OI in Sillence Classification].<xref ref-type="bibr" rid="article-26388.r9">[9]</xref> Alternatively, errors in substitution or deletion involving a glycine peptide residue along the polypeptide chain can result in the production of structurally or qualitatively abnormal or less effectual collagen.&#x000a0;The phenotypic expression of these defects depends on the position of substitution, whether glycine substitutes at the carboxy-terminal (severe form) or the amino-terminal (milder form) of the polypeptide chains.<xref ref-type="bibr" rid="article-26388.r14">[14]</xref></p>
        <p>Substitutions at the carboxy end of the peptide are potentially more serious owing to cross-linking of the triple helix beginning at the carboxy terminus of polypeptide chains. These patients with mutations of glycine residues affecting the quality of collagen chains (commonly identified defects in Sillence types II, III, and IV types) develop more severe skeletal manifestations than patients with haploinsufficiency defects.<xref ref-type="bibr" rid="article-26388.r15">[15]</xref></p>
        <p>
<bold>Other Mutations</bold>
</p>
        <p>Apart from type I collagen mutations, other genetic mutations producing autosomal recessive types of OI (types VI, VII, VIII, IX, X, and XI) have also been described. These mutations may involve components that encode collagen 3-hydroxylation complex, which helps assemble the triple helix. These recessive mutational types account for less than 5% of the cases of OI collectively.<xref ref-type="bibr" rid="article-26388.r15">[15]</xref></p>
      </sec>
      <sec id="article-26388.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Generally, the defects involving&#x000a0;decreased collagen type 1 secretion or secretion of abnormal collagen&#x000a0;result in insufficient osteoid production.<xref ref-type="bibr" rid="article-26388.r16">[16]</xref> Both enchondral and intramembranous ossification are affected. Thin, poorly organized bony trabeculae and collagen matrix, scanty spongiosa; a relative abundance of osteoblasts and osteoclasts, increased bone turnover; and broad, irregular physes with disorganized proliferative and hypertrophic zones, as well as thinned calcified zone, are typical histological features.<xref ref-type="bibr" rid="article-26388.r17">[17]</xref>&#x000a0;Newer studies have proposed problems with specific growth factors, particularly transforming growth factor beta (TGFb), so completely innovative treatments are being developed to neutralize this factor with a specialized antibody.<xref ref-type="bibr" rid="article-26388.r18">[18]</xref></p>
      </sec>
      <sec id="article-26388.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Two clinically useful classification systems of osteogenesis imperfecta have been described by Sillence et al. and Shapiro et al.<xref ref-type="bibr" rid="article-26388.r7">[7]</xref><xref ref-type="bibr" rid="article-26388.r19">[19]</xref><xref ref-type="bibr" rid="article-26388.r10">[10]</xref> In 1979, Sillence and Danks initially described four types of OI based on the clinical and genetic basis. They originally identified types I and IV as autosomal dominant and types II and III as autosomal recessive inheritance. More recent literature has shown that true autosomal recessive inheritance is quite rare. Based on further research on the genetic defects involved, Cole further added types V to XI to the original Sillence Classification (type V with autosomal dominant and types VI to XI with autosomal recessive transmissions).<xref ref-type="bibr" rid="article-26388.r12">[12]</xref><xref ref-type="bibr" rid="article-26388.r4">[4]</xref></p>
        <p>Osteogenesis imperfecta classification based on phenotypic characteristics and mode of inheritance modified from Sillence et al.:</p>
        <list list-type="bullet">
          <list-item>
            <p>Type I: Autosomal dominant (COL1A1 gene does not produce viable mRNA for procollagen); collagen amount is 50% reduced; however, the molecule is structurally normal. General manifestation shows generalized osteoporosis, abnormal bone fragility (fractures typically during the ambulatory years of child development and&#x000a0;reduced bone&#x000a0;maturity), blue sclera, conductive deafness, and mild stunting. IA (Normal Teeth), IB/IC (dentinogenesis imperfecta).<xref ref-type="bibr" rid="article-26388.r9">[9]</xref><xref ref-type="bibr" rid="article-26388.r6">[6]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Type II: Originally classified as autosomal recessive; however, recent work indicates that it follows a dominant negative inheritance (7% risk of disease in subsequent pregnancies), often due to spontaneous mutation. This form results in severe disruption in the qualitative function of the collagen molecule: lethal perinatal form. General manifestation demonstrates extreme bone fragility (accordion femur), delayed skull ossification, blue sclera, and perinatal death. Type IIA&#x000a0; has short and wide long bones with fractures and wide ribs with sparse fractures.&#x000a0;II-B manifests with short and widened long bones with fractures and ribs with sparse fractures. II-C presents with thin, long bones with fractures and thin ribs.<xref ref-type="bibr" rid="article-26388.r20">[20]</xref><xref ref-type="bibr" rid="article-26388.r12">[12]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Type III: Autosomal recessive or dominant negative inheritance; type I collagen alteration is both qualitative and quantitative. Most children with severe clinical manifestations belong to this category. General manifestation presents with blue sclera in infancy and returns to normal hue in adolescence. Moderate to severe bone fragility, coxa vara, multiple fractures, and marked long bone deformities (more severe than type I with greater ambulation difficulties). These patients require intramedullary nailing prophylactically. Other specific features: Early onset scoliosis, triangular facies, frontal bossing, basilar invagination, and extremely short stature.<xref ref-type="bibr" rid="article-26388.r3">[3]</xref><xref ref-type="bibr" rid="article-26388.r21">[21]</xref><xref ref-type="bibr" rid="article-26388.r13">[13]</xref><xref ref-type="bibr" rid="article-26388.r22">[22]</xref><xref ref-type="bibr" rid="article-26388.r23">[23]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Type IV: Heterogenous group; autosomal dominant that also has qualitative and quantitative changes in type I collagen&#x02014;more severe clinical manifestations than type I OI. General manifestation shows normal sclera, moderate to severe bone fragility and&#x000a0;deformity of the long bones and spinal column, and moderate to severe&#x000a0;growth stunting. Type IV A presents with normal teeth, while Type IV B shows dentinogenesis imperfect.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Type V:&#x000a0;Autosomal dominant; mutation in the gene encoding interferon-induced transmembrane protein-5&#x000a0;(IFITM5); histologically demonstrates a mesh-like appearance of the lamellar bone. It presents with mild to moderate degrees of severity. Specific features include normal sclera, the absence of dental involvement, calcification of interosseous membrane, especially the forearm that can lead to secondary dislocation of the radius, hypertrophic callus, and a radiodense band near long bone physis are specific characteristics of this type.<xref ref-type="bibr" rid="article-26388.r24">[24]</xref><xref ref-type="bibr" rid="article-26388.r25">[25]</xref><xref ref-type="bibr" rid="article-26388.r26">[26]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Type VI: Mutation involving SERPINF1 gene; characteristic histological presentation includes lamellar bone with fish scale pattern under a polarized light microscope and severe mineralization defects. This type presents with moderate to severe skeletal manifestations, normal sclera, and an absence of dental involvement.</p>
          </list-item>
        </list>
        <p>
<bold>Types VII, VIII, and IX</bold>
</p>
        <p>
<bold>Common Features</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>A defect in the prolyl 3-hydroxylation complex in the endoplasmic reticulum (ER) (which helps in the assembly of the triple helix)</p>
          </list-item>
          <list-item>
            <p>Autosomal recessive<xref ref-type="bibr" rid="article-26388.r4">[4]</xref><xref ref-type="bibr" rid="article-26388.r27">[27]</xref><xref ref-type="bibr" rid="article-26388.r28">[28]</xref></p>
          </list-item>
        </list>
        <p>Specific defects include cartilage-associated protein defects (CRTAP) - type VII, prolyl 3-hydroxylase (LEPRE1) - type VIII, and peptidyl-prolyl cis-trans isomerase B (PPIB) - type IX.</p>
        <p>
<bold>General Manifestation</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Type VII: Moderate to severe. It is associated with rhizomelia and coxa vara.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Type VIII: Severe to lethal.&#x000a0;It is associated with rhizomelia.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Type IX: &#x000a0;Severe autosomal recessive form.</p>
          </list-item>
        </list>
        <p>
<bold>Types X and XI</bold>
</p>
        <p>
<bold>Common Features</bold>
</p>
        <list list-type="order">
          <list-item>
            <p>A defect in collagen chaperones that accompany procollagen molecules from ER to Golgi apparatus</p>
          </list-item>
          <list-item>
            <p>2.Autosomal recessive<xref ref-type="bibr" rid="article-26388.r28">[28]</xref><xref ref-type="bibr" rid="article-26388.r29">[29]</xref></p>
          </list-item>
        </list>
        <p>Specific defects: SERPINH1 - type X, FKBP10 - type XI.</p>
        <p>
<bold>General Manifestation&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Type X: Severe bone dysplasia, dentinogenesis imperfecta, transient skin bullae, blue sclera, pyloric stenosis, and renal stones.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Type XI: Bone dysplasia, ligamentous laxity, scoliosis, and platyspondyly.&#x000a0;Normal sclera and&#x000a0;absence of dental involvement.</p>
          </list-item>
        </list>
        <p>The pitfall of Sillence Classification: Significant variability in the severity of deformities and fractures within different classification categories. Less prognostic&#x000a0;relevance.</p>
        <p>Looser et al. (1906):</p>
        <p>Classified OI into two types - OI congenita (presence of numerous fractures at birth) and OI tarda (fractures occur after the perinatal period).</p>
        <p>Shapiro's modification of Looser classification (4 types): Excellent practical application regarding prognostication for survival and ambulation.<xref ref-type="bibr" rid="article-26388.r10">[10]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Congenita A (Incompatible with life) - Sustain fractures in utero or at birth; Radiographically, present with crumpled long bones, crumpled ribs, rib cage deformity, and fragile skull.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Congenita B (Compatible with survival) -&#x000a0;Sustain fractures in utero or at birth; Radiographically, present with more tubular long bones with funnelization in the metaphysis, normally formed ribs, and no rib cage deformity.</p>
          </list-item>
        </list>
        <p>Tarda A - Fractures before walking; Age of onset of fractures - not prognostic for ambulation.</p>
        <p>Tarda B - First fracture after walking age; All patients usually ambulate.</p>
      </sec>
      <sec id="article-26388.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>It is important to rule out non-accidental trauma in these patients presenting with multiple fractures.<xref ref-type="bibr" rid="article-26388.r30">[30]</xref><xref ref-type="bibr" rid="article-26388.r31">[31]</xref></p>
        <p>Diagnosis: is based on clinical and family history, bone mineral density (lumbar vertebra), bone biochemistry, and radiographic features.<xref ref-type="bibr" rid="article-26388.r32">[32]</xref></p>
        <p>The most common clinical finding is bone fragility in most OI types. Most of them have specific features, as described by&#x000a0;Van Dijk and Sillence.<xref ref-type="bibr" rid="article-26388.r33">[33]</xref></p>
        <p>Patients usually present with four Major Clinical Features:</p>
        <list list-type="bullet">
          <list-item>
            <p>Decreased bone mass, increased bone fragility</p>
          </list-item>
          <list-item>
            <p>Blue sclera</p>
          </list-item>
          <list-item>
            <p>Dentinogenesis imperfecta (Normal enamel with dentin abnormality)</p>
          </list-item>
          <list-item>
            <p>Hearing loss</p>
          </list-item>
          <list-item>
            <p>Other features include ligament laxity, increased joint mobility, short stature, and easy bruising.</p>
          </list-item>
        </list>
        <p>Fractures in OI: the earlier the onset of fractures, the poorer the prognosis is.<xref ref-type="bibr" rid="article-26388.r34">[34]</xref><xref ref-type="bibr" rid="article-26388.r35">[35]</xref> There is a possibility of hypertrophic callus during fracture healing (which may resemble osteosarcoma); however, the fractures, on most occasions, heal at the usual rate. Bony deformities may occur secondary to fractures; protrusio acetabuli, proximal varus or anterolateral bowing (femur), anterior bow (tibia), cubitus varus, and other proximal forearm deformities are known to occur.<xref ref-type="bibr" rid="article-26388.r36">[36]</xref>&#x000a0;</p>
        <p>Facies in OI: Elfin facies, helmet head appearance.</p>
        <p>Manifestations depend on the type of&#x000a0;OI.</p>
        <p>Laboratory: no commercially available diagnostic test is available&#x000a0;due to a wide&#x000a0;variety of genetic mutations. Laboratory values are typically within the normal range with potentially mildly elevated alkaline phosphatase (ALP).</p>
        <p>
<bold>Plain Radiograph</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Head, neck, and Spine: wormian bones, basilar invagination, kyphoscoliosis (39 to 100%), platyspondyly</p>
          </list-item>
          <list-item>
            <p>Chest: pectus excavatum or carinatum</p>
          </list-item>
          <list-item>
            <p>Pelvis: protusio acetabuli, coxa vara</p>
          </list-item>
          <list-item>
            <p>General: osteoporosis, lack of funneling of long bones, cortical thinning, hypertrophic callus&#x000a0;formation, popcorn calcifications involving metaphysis and epiphysis, pseudoarthrosis at the site of fractures</p>
          </list-item>
        </list>
        <p>Prenatal ultrasound: decreased calvarial ossification, shortened and angulated long bones, multiple bone fractures, a beaded appearance of ribs, polyhydramnios.<xref ref-type="bibr" rid="article-26388.r37">[37]</xref></p>
        <p>
<bold>Computed Tomography (CT)</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Wormian bone</p>
          </list-item>
          <list-item>
            <p>Basilar invagination</p>
          </list-item>
          <list-item>
            <p>Otosclerosis</p>
          </list-item>
          <list-item>
            <p>Long bone fractures<xref ref-type="bibr" rid="article-26388.r38">[38]</xref></p>
          </list-item>
        </list>
        <p><bold>Magnetic Resonance Imaging (MRI)</bold> (to evaluate basilar invagination)</p>
        <p>Fibroblast culturing to analyze type I collagen (positive in 80% of type IV): used for confirmation of the diagnosis in equivocal cases</p>
        <p>
<bold>Biopsy</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Collagen analysis of a punch biopsy</p>
          </list-item>
          <list-item>
            <p>Iliac crest biopsy which demonstrates a decrease in cortical widths and the volume of cancellous bone, with increased bone remodeling</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26388.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Management varies with the age, severity, and functional status of patients:</p>
        <list list-type="bullet">
          <list-item>
            <p>Mild disease: subtle restriction, avoid contact sports, treated for any fractures<xref ref-type="bibr" rid="article-26388.r39">[39]</xref></p>
          </list-item>
          <list-item>
            <p>Moderate to Severe disease: rehabilitation and orthopedic interventions, management of acute fractures and scoliosis<xref ref-type="bibr" rid="article-26388.r40">[40]</xref></p>
          </list-item>
          <list-item>
            <p>Severe disease: an intramedullary rod with osteotomy used to correct severe bowing of long bones<xref ref-type="bibr" rid="article-26388.r41">[41]</xref><xref ref-type="bibr" rid="article-26388.r42">[42]</xref></p>
          </list-item>
        </list>
        <p><bold>Medical Management</bold>&#x000a0;</p>
        <p>Medical management can take a number of forms, as listed below.<xref ref-type="bibr" rid="article-26388.r43">[43]</xref><xref ref-type="bibr" rid="article-26388.r44">[44]</xref><xref ref-type="bibr" rid="article-26388.r45">[45]</xref><xref ref-type="bibr" rid="article-26388.r46">[46]</xref><xref ref-type="bibr" rid="article-26388.r47">[47]</xref><xref ref-type="bibr" rid="article-26388.r48">[48]</xref><xref ref-type="bibr" rid="article-26388.r49">[49]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Sex hormones, sodium fluoride, calcium, calcitonin, magnesium oxide, and vitamins C and D - attempted in the past with no or mixed results.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Bisphosphonates (intravenous pamidronate, oral alendronate) have been demonstrated to be useful (decrease fracture risk, improve bone mineral density as well as ambulatory status) through their ability to reduce the osteoclastic resorption of bone in children with OI<xref ref-type="bibr" rid="article-26388.r50">[50]</xref><xref ref-type="bibr" rid="article-26388.r51">[51]</xref><xref ref-type="bibr" rid="article-26388.r52">[52]</xref><xref ref-type="bibr" rid="article-26388.r53">[53]</xref><xref ref-type="bibr" rid="article-26388.r52">[52]</xref></p>
          </list-item>
          <list-item>
            <p>Gene therapy and cell transplantation (to correct defective COL1A1 and COL1A2 genes) are still not widely available, but experimental studies in animals showed promising results<xref ref-type="bibr" rid="article-26388.r54">[54]</xref><xref ref-type="bibr" rid="article-26388.r55">[55]</xref><xref ref-type="bibr" rid="article-26388.r56">[56]</xref></p>
          </list-item>
          <list-item>
            <p>Sclerostin antibody medication (romosozumab) has been used in animal models with beneficial effects on the skeleton, but there are no human studies reported yet<xref ref-type="bibr" rid="article-26388.r57">[57]</xref><xref ref-type="bibr" rid="article-26388.r58">[58]</xref><xref ref-type="bibr" rid="article-26388.r59">[59]</xref><xref ref-type="bibr" rid="article-26388.r60">[60]</xref><xref ref-type="bibr" rid="article-26388.r57">[57]</xref></p>
          </list-item>
          <list-item>
            <p>Denosumab has been proven to help with bone quality in small-scale studies, but it is not yet approved for wide use in OI patients; ongoing studies are looking into more details of this treatment<xref ref-type="bibr" rid="article-26388.r61">[61]</xref></p>
          </list-item>
          <list-item>
            <p>Anabolic bone therapy with teriparatide was also tried in a small study and showed an increase in the bone density of the OI-treated patients compared to the placebo group,&#x000a0;but this medication is also not officially approved for use in this population<xref ref-type="bibr" rid="article-26388.r62">[62]</xref></p>
          </list-item>
          <list-item>
            <p>An antibody to transforming&#x000a0;growth factor beta (TGFb) is one of the latest medical treatments studied in animal models with OI, and it has also offered some promising results<xref ref-type="bibr" rid="article-26388.r18">[18]</xref><xref ref-type="bibr" rid="article-26388.r63">[63]</xref><xref ref-type="bibr" rid="article-26388.r64">[64]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Orthopedic Management</bold>
</p>
        <p>The goals focus on ways to ameliorate patient functional status, prevent deformity and disability, correct deformities, and monitor for complications.</p>
        <p>1. Orthotic treatment: orthosis, walking aids, wheelchairs</p>
        <p>2. Management of long bone fractures</p>
        <p>3. Management of long bone deformities includes:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>In infants and children:&#x000a0;&#x000a0;
<list list-type="bullet"><list-item><p>Closed osteoclasis without intramedullary fixation</p></list-item><list-item><p>Closed osteoclasis with percutaneous intramedullary fixation</p></list-item><list-item><p>Open osteotomy with internal fixation (Sofield and Millar procedure) - Rush nail, Williams rod<xref ref-type="bibr" rid="article-26388.r65">[65]</xref><xref ref-type="bibr" rid="article-26388.r66">[66]</xref><xref ref-type="bibr" rid="article-26388.r67">[67]</xref><xref ref-type="bibr" rid="article-26388.r68">[68]</xref></p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>In young adult patients:
<list list-type="bullet"><list-item><p>External fixation with circular or uniplanar constructs with osteotomy.</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>4. Prophylactic intramedullary rod for children who repeatedly fracture their long bones. Different types of&#x000a0;rods according to bone size and&#x000a0;skeletal maturity are used:</p>
        <list list-type="bullet">
          <list-item>
            <p>Osteotomy and&#x000a0;fixation with telescoping rod (Bailey-Dubow rod, Sheffield rod, Fassier-Duval rod)</p>
          </list-item>
          <list-item>
            <p>Osteotomy and&#x000a0;fixation&#x000a0;with a non-telescoping rod (Kirschner wire, Steinmann pin, Williams rod, push rod, other fixed-length rods)</p>
          </list-item>
        </list>
        <p>5. Management of spinal deformities: basilar invagination, kyphoscoliosis, spinal fractures</p>
      </sec>
      <sec id="article-26388.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Major differentials include:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Congenital hypophosphatasia<xref ref-type="bibr" rid="article-26388.r30">[30]</xref></p>
          </list-item>
          <list-item>
            <p>Achondroplasia</p>
          </list-item>
          <list-item>
            <p>Pyknodysostosis<xref ref-type="bibr" rid="article-26388.r31">[31]</xref></p>
          </list-item>
          <list-item>
            <p>Diffuse osteopenia in the early stages of leukemia<xref ref-type="bibr" rid="article-26388.r69">[69]</xref></p>
          </list-item>
          <list-item>
            <p>Idiopathic juvenile osteoporosis</p>
          </list-item>
          <list-item>
            <p>Child abuse or battered child syndrome<xref ref-type="bibr" rid="article-26388.r70">[70]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26388.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Varied across the diverse spectrum of the disease.<xref ref-type="bibr" rid="article-26388.r10">[10]</xref></p>
        <p>As previously discussed, the Shapiro classification (more than the Sillence classification) is a good prognostic indicator.&#x000a0;</p>
        <p>The age of onset of long bone fractures has been demonstrated as an important prognostic indicator for ambulatory ability.</p>
        <p>Survival: The most significant indicators include the location&#x000a0;and&#x000a0;severity of fractures and the general radiographic appearance of the skeleton.</p>
        <p>Engelbert et al. demonstrated that children who achieved independent sitting or standing, or both, by 12 years of age were finally able to ambulate.&#x000a0;</p>
        <p>The authors also found that children who could achieve independent sitting or standing, or both, at 12 months old were likely to be able to walk.<xref ref-type="bibr" rid="article-26388.r71">[71]</xref></p>
      </sec>
      <sec id="article-26388.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The following complications may present with osteogenesis imperfecta:</p>
        <list list-type="order">
          <list-item>
            <p>Hyperplastic callus formation is rare and managed by conservative, palliative radiotherapy (caution: secondary malignancy) and bisphosphonates<xref ref-type="bibr" rid="article-26388.r72">[72]</xref></p>
          </list-item>
          <list-item>
            <p>Tumors: Osteogenic sarcoma<xref ref-type="bibr" rid="article-26388.r73">[73]</xref></p>
          </list-item>
          <list-item>
            <p>Basilar invagination: Cranial nerve involvement, direct brain stem compression, altered cerebrospinal fluid (CSF) dynamics<xref ref-type="bibr" rid="article-26388.r74">[74]</xref></p>
          </list-item>
          <list-item>
            <p>Malignant hyperthermia: both the surgeon and anesthesiologist&#x000a0;should keep in mind the possibility of malignant hyperthermia during anesthesia<xref ref-type="bibr" rid="article-26388.r75">[75]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26388.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>It is vital to educate the parent regarding the likelihood of survival and what to expect regarding deformity, disability, and ambulatory capacity. Genetic counseling and prenatal screening (including ultrasonography) may be necessary during future pregnancies. The parents should also receive counseling that their children, despite their orthopedic impairments, have normal intelligence and social abilities. They should also receive information regarding the need for caution against falls to obviate recurrent fragility fractures.<xref ref-type="bibr" rid="article-26388.r76">[76]</xref></p>
        <p>Antenatal diagnosis:</p>
        <p>Antenatal ultrasound can demonstrate OI Sillence type II by 16 weeks of fetal age. Based on the severity of disease expression, Sillence types I, III, and IV can also be diagnosable on imaging.<xref ref-type="bibr" rid="article-26388.r3">[3]</xref></p>
        <p>Parents with a history of a fetus affected by OI type II carry a 2% to 7% risk of a similarly affected fetus in future pregnancies. Antenatal diagnosis can be made in such scenarios by DNA analysis of chorionic villus samples obtained by ultrasonographic imaging.</p>
      </sec>
      <sec id="article-26388.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of osteogenesis imperfecta is challenging and complex and requires an interprofessional healthcare team approach to management.<xref ref-type="bibr" rid="article-26388.r76">[76]</xref> The primary reason underlying the complexity of management is the wide variation in the phenotypic expression across the different spectra of the disease. The significant role of early diagnosis (clinical, imaging, biochemical, and genetic evaluation) and early risk stratification in the long-term management of the child should never be understated. The importance of an interprofessional intervention over the long term involving a family physician, pediatrician, endocrinologist, radiologist, orthopedic surgeon, neurosurgeon, anesthesiologist, mid-level practitioners (NPS and PAs), orthotic expert, occupational therapist, physiotherapist, and&#x000a0;pharmacist over different stages of management needs to be understood. The orthopedic surgeon is involved in preventing and managing fractures and deformities of extremities.</p>
        <p>Medical management with bisphosphonates can prevent fractures in children with recurrent fractures. The pharmacist can perform medication reconciliation, verify dosing, counsel parents on the potential adverse effects, and answer their medication questions. If they note any concerns in the patient's medication regimen, they must immediately contact the prescriber or nurse to implement corrective measures. A neurosurgeon may be involved in managing upper cervical spine/craniocervical junction compressive pathologies or spinal deformities. The role of parent education on what to expect at different stages of disease management is also highly significant. Nurses can play a vital role in imparting holistic care to the patient and providing the needed support to the caregivers. Such interprofessional care can aid in meeting basic goals in the management of OI, including ameliorating the patient's functional status, preventing deformity and disability, correcting existing deformities, and monitoring for possible complications.</p>
        <p>Most of the current knowledge on the subject of OI has its basis in available level 3 to 5&#x000a0;evidence.</p>
      </sec>
      <sec id="article-26388.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26388&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26388">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/osteogenesis-imperfecta-brittle-bone-disease/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=26388">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26388/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26388">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-26388.s16">
        <title>References</title>
        <ref id="article-26388.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Uttarilli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bhavani</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Upadhyai</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shukla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Girisha</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Phenotyping and genotyping of skeletal dysplasias: Evolution of a center and a decade of experience in India.</article-title>
            <source>Bone</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>120</volume>
            <fpage>204</fpage>
            <page-range>204-211</page-range>
            <pub-id pub-id-type="pmid">30408610</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nicol</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Morar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Henriksen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Karsdal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nagamani</surname>
                <given-names>SCS</given-names>
              </name>
              <name>
                <surname>Shapiro</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Orwoll</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Alterations in non-type I collagen biomarkers in osteogenesis imperfecta.</article-title>
            <source>Bone</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>120</volume>
            <fpage>70</fpage>
            <page-range>70-74</page-range>
            <pub-id pub-id-type="pmid">30290234</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ablin</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Osteogenesis imperfecta: a review.</article-title>
            <source>Can Assoc Radiol J</source>
            <year>1998</year>
            <month>Apr</month>
            <volume>49</volume>
            <issue>2</issue>
            <fpage>110</fpage>
            <page-range>110-23</page-range>
            <pub-id pub-id-type="pmid">9561014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Forlino</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cabral</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Barnes</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Marini</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>New perspectives on osteogenesis imperfecta.</article-title>
            <source>Nat Rev Endocrinol</source>
            <year>2011</year>
            <month>Jun</month>
            <day>14</day>
            <volume>7</volume>
            <issue>9</issue>
            <fpage>540</fpage>
            <page-range>540-57</page-range>
            <pub-id pub-id-type="pmid">21670757</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Valadares</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Carneiro</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Zabel</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>What is new in genetics and osteogenesis imperfecta classification?</article-title>
            <source>J Pediatr (Rio J)</source>
            <year>2014</year>
            <season>Nov-Dec</season>
            <volume>90</volume>
            <issue>6</issue>
            <fpage>536</fpage>
            <page-range>536-41</page-range>
            <pub-id pub-id-type="pmid">25046257</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Warman</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Cormier-Daire</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Krakow</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lachman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>LeMerrer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mortier</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mundlos</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nishimura</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rimoin</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Robertson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Savarirayan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sillence</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Spranger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Unger</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zabel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Superti-Furga</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Nosology and classification of genetic skeletal disorders: 2010 revision.</article-title>
            <source>Am J Med Genet A</source>
            <year>2011</year>
            <month>May</month>
            <volume>155A</volume>
            <issue>5</issue>
            <fpage>943</fpage>
            <page-range>943-68</page-range>
            <pub-id pub-id-type="pmid">21438135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sillence</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Osteogenesis imperfecta: an expanding panorama of variants.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>1981</year>
            <month>Sep</month>
            <issue>159</issue>
            <fpage>11</fpage>
            <page-range>11-25</page-range>
            <pub-id pub-id-type="pmid">7285446</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stoltz</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Dietrich</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Marshall</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Osteogenesis imperfecta. Perspectives.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>1989</year>
            <month>May</month>
            <issue>242</issue>
            <fpage>120</fpage>
            <page-range>120-36</page-range>
            <pub-id pub-id-type="pmid">2650946</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sillence</surname>
                <given-names>DO</given-names>
              </name>
              <name>
                <surname>Senn</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Danks</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Genetic heterogeneity in osteogenesis imperfecta.</article-title>
            <source>J Med Genet</source>
            <year>1979</year>
            <month>Apr</month>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>101</fpage>
            <page-range>101-16</page-range>
            <pub-id pub-id-type="pmid">458828</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shapiro</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Consequences of an osteogenesis imperfecta diagnosis for survival and ambulation.</article-title>
            <source>J Pediatr Orthop</source>
            <year>1985</year>
            <season>Jul-Aug</season>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>456</fpage>
            <page-range>456-62</page-range>
            <pub-id pub-id-type="pmid">4019761</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tam</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shapiro</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Steiner</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Bober</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cuthbertson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Krischer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mullins</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bellur</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Byers</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Pepin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Durigova</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Glorieux</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Rauch</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sutton</surname>
                <given-names>VR</given-names>
              </name>
              <collab>, Members of the Brittle Bone Disorders Consortium*,</collab>
              <name>
                <surname>Nagamani</surname>
                <given-names>SCS</given-names>
              </name>
            </person-group>
            <article-title>Growth characteristics in individuals with osteogenesis imperfecta in North America: results from a multicenter study.</article-title>
            <source>Genet Med</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>275</fpage>
            <page-range>275-283</page-range>
            <pub-id pub-id-type="pmid">29970925</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cole</surname>
                <given-names>WG</given-names>
              </name>
            </person-group>
            <article-title>The Nicholas Andry Award-1996. The molecular pathology of osteogenesis imperfecta.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>1997</year>
            <month>Oct</month>
            <issue>343</issue>
            <fpage>235</fpage>
            <page-range>235-48</page-range>
            <pub-id pub-id-type="pmid">9345229</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Minch</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Kruse</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Osteogenesis imperfecta: a review of basic science and diagnosis.</article-title>
            <source>Orthopedics</source>
            <year>1998</year>
            <month>May</month>
            <volume>21</volume>
            <issue>5</issue>
            <fpage>558</fpage>
            <page-range>558-67; quiz 568-9</page-range>
            <pub-id pub-id-type="pmid">9606696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Makareeva</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mertz</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Kuznetsova</surname>
                <given-names>NV</given-names>
              </name>
              <name>
                <surname>Sutter</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>DeRidder</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Cabral</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Barnes</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>McBride</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Marini</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Leikin</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Structural heterogeneity of type I collagen triple helix and its role in osteogenesis imperfecta.</article-title>
            <source>J Biol Chem</source>
            <year>2008</year>
            <month>Feb</month>
            <day>22</day>
            <volume>283</volume>
            <issue>8</issue>
            <fpage>4787</fpage>
            <page-range>4787-98</page-range>
            <pub-id pub-id-type="pmid">18073209</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rauch</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lalic</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Roughley</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Glorieux</surname>
                <given-names>FH</given-names>
              </name>
            </person-group>
            <article-title>Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta.</article-title>
            <source>J Bone Miner Res</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>25</volume>
            <issue>6</issue>
            <fpage>1367</fpage>
            <page-range>1367-74</page-range>
            <pub-id pub-id-type="pmid">19929435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoyer-Kuhn</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Netzer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Semler</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Osteogenesis imperfecta: pathophysiology and treatment.</article-title>
            <source>Wien Med Wochenschr</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>165</volume>
            <issue>13-14</issue>
            <fpage>278</fpage>
            <page-range>278-84</page-range>
            <pub-id pub-id-type="pmid">26055811</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doty</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Mathews</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Electron microscopic and histochemical investigation of osteogenesis imperfecta tarda.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>1971</year>
            <month>Oct</month>
            <volume>80</volume>
            <fpage>191</fpage>
            <page-range>191-201</page-range>
            <pub-id pub-id-type="pmid">5133325</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grafe</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Alexander</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Homan</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Lietman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Bertin</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Munivez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Dawson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ishikawa</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Weis</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Sampath</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Ambrose</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Eyre</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>B&#x000e4;chinger</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Excessive transforming growth factor-&#x003b2; signaling is a common mechanism in osteogenesis imperfecta.</article-title>
            <source>Nat Med</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>20</volume>
            <issue>6</issue>
            <fpage>670</fpage>
            <page-range>670-5</page-range>
            <pub-id pub-id-type="pmid">24793237</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sillence</surname>
                <given-names>DO</given-names>
              </name>
              <name>
                <surname>Rimoin</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Danks</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Clinical variability in osteogenesis imperfecta-variable expressivity or genetic heterogeneity.</article-title>
            <source>Birth Defects Orig Artic Ser</source>
            <year>1979</year>
            <volume>15</volume>
            <issue>5B</issue>
            <fpage>113</fpage>
            <page-range>113-29</page-range>
            <pub-id pub-id-type="pmid">393318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sanguinetti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Greco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>De Palma</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Specchia</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Falciglia</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Morphological changes in growth-plate cartilage in osteogenesis imperfecta.</article-title>
            <source>J Bone Joint Surg Br</source>
            <year>1990</year>
            <month>May</month>
            <volume>72</volume>
            <issue>3</issue>
            <fpage>475</fpage>
            <page-range>475-9</page-range>
            <pub-id pub-id-type="pmid">2187879</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cole</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Jaenisch</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bateman</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>New insights into the molecular pathology of osteogenesis imperfecta.</article-title>
            <source>Q J Med</source>
            <year>1989</year>
            <month>Jan</month>
            <volume>70</volume>
            <issue>261</issue>
            <fpage>1</fpage>
            <page-range>1-4</page-range>
            <pub-id pub-id-type="pmid">2687927</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nicholls</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Oliver</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Renouf</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>Keston</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pope</surname>
                <given-names>FM</given-names>
              </name>
            </person-group>
            <article-title>Substitution of cysteine for glycine at residue 415 of one allele of the alpha 1(I) chain of type I procollagen in type III/IV osteogenesis imperfecta.</article-title>
            <source>J Med Genet</source>
            <year>1991</year>
            <month>Nov</month>
            <volume>28</volume>
            <issue>11</issue>
            <fpage>757</fpage>
            <page-range>757-64</page-range>
            <pub-id pub-id-type="pmid">1770532</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aarabi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rauch</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Hamdy</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Fassier</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>High prevalence of coxa vara in patients with severe osteogenesis imperfecta.</article-title>
            <source>J Pediatr Orthop</source>
            <year>2006</year>
            <season>Jan-Feb</season>
            <volume>26</volume>
            <issue>1</issue>
            <fpage>24</fpage>
            <page-range>24-8</page-range>
            <pub-id pub-id-type="pmid">16439896</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cho</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Jeon</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>HN</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Eom</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>ZH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>OH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>WY</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Ikegawa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yoo</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>A single recurrent mutation in the 5'-UTR of IFITM5 causes osteogenesis imperfecta type V.</article-title>
            <source>Am J Hum Genet</source>
            <year>2012</year>
            <month>Aug</month>
            <day>10</day>
            <volume>91</volume>
            <issue>2</issue>
            <fpage>343</fpage>
            <page-range>343-8</page-range>
            <pub-id pub-id-type="pmid">22863190</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glorieux</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Rauch</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Plotkin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Travers</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Roughley</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lalic</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Glorieux</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Fassier</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bishop</surname>
                <given-names>NJ</given-names>
              </name>
            </person-group>
            <article-title>Type V osteogenesis imperfecta: a new form of brittle bone disease.</article-title>
            <source>J Bone Miner Res</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>15</volume>
            <issue>9</issue>
            <fpage>1650</fpage>
            <page-range>1650-8</page-range>
            <pub-id pub-id-type="pmid">10976985</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Semler</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Garbes</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Keupp</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Swan</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zimmermann</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Iden</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wirth</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Eysel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Koerber</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Schoenau</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bohlander</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Wollnik</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Netzer</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>A mutation in the 5'-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus.</article-title>
            <source>Am J Hum Genet</source>
            <year>2012</year>
            <month>Aug</month>
            <day>10</day>
            <volume>91</volume>
            <issue>2</issue>
            <fpage>349</fpage>
            <page-range>349-57</page-range>
            <pub-id pub-id-type="pmid">22863195</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morello</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bertin</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hicks</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tonachini</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Monticone</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Castagnola</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rauch</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Glorieux</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Vranka</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>B&#x000e4;chinger</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Pace</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Schwarze</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Byers</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Weis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fernandes</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Eyre</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Boyce</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta.</article-title>
            <source>Cell</source>
            <year>2006</year>
            <month>Oct</month>
            <day>20</day>
            <volume>127</volume>
            <issue>2</issue>
            <fpage>291</fpage>
            <page-range>291-304</page-range>
            <pub-id pub-id-type="pmid">17055431</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Dijk</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Nesbitt</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Zwikstra</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Nikkels</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Piersma</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Fratantoni</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Jimenez</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Huizer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Morsman</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Cobben</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>van Roij</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Elting</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Verbeke</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Wijnaendts</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>H&#x000f6;gler</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>McKeown</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sistermans</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Dalton</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Meijers-Heijboer</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pals</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>PPIB mutations cause severe osteogenesis imperfecta.</article-title>
            <source>Am J Hum Genet</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>85</volume>
            <issue>4</issue>
            <fpage>521</fpage>
            <page-range>521-7</page-range>
            <pub-id pub-id-type="pmid">19781681</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Christiansen</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>Schwarze</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Pyott</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>AlSwaid</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Al Balwi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alrasheed</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pepin</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Weis</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Eyre</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Byers</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta.</article-title>
            <source>Am J Hum Genet</source>
            <year>2010</year>
            <month>Mar</month>
            <day>12</day>
            <volume>86</volume>
            <issue>3</issue>
            <fpage>389</fpage>
            <page-range>389-98</page-range>
            <pub-id pub-id-type="pmid">20188343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Augarten</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Laufer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Szeinberg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Passwell</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Child abuse, osteogenesis imperfecta and the grey zone between them.</article-title>
            <source>J Med</source>
            <year>1993</year>
            <volume>24</volume>
            <issue>2-3</issue>
            <fpage>171</fpage>
            <page-range>171-5</page-range>
            <pub-id pub-id-type="pmid">8409779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Knight</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Bennet</surname>
                <given-names>GC</given-names>
              </name>
            </person-group>
            <article-title>Nonaccidental injury in osteogenesis imperfecta: a case report.</article-title>
            <source>J Pediatr Orthop</source>
            <year>1990</year>
            <season>Jul-Aug</season>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>542</fpage>
            <page-range>542-4</page-range>
            <pub-id pub-id-type="pmid">2358497</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trejo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rauch</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment.</article-title>
            <source>Osteoporos Int</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>27</volume>
            <issue>12</issue>
            <fpage>3427</fpage>
            <page-range>3427-3437</page-range>
            <pub-id pub-id-type="pmid">27492436</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Dijk</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Sillence</surname>
                <given-names>DO</given-names>
              </name>
            </person-group>
            <article-title>Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment.</article-title>
            <source>Am J Med Genet A</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>164A</volume>
            <issue>6</issue>
            <fpage>1470</fpage>
            <page-range>1470-81</page-range>
            <pub-id pub-id-type="pmid">24715559</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gamble</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Rinsky</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Strudwick</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bleck</surname>
                <given-names>EE</given-names>
              </name>
            </person-group>
            <article-title>Non-union of fractures in children who have osteogenesis imperfecta.</article-title>
            <source>J Bone Joint Surg Am</source>
            <year>1988</year>
            <month>Mar</month>
            <volume>70</volume>
            <issue>3</issue>
            <fpage>439</fpage>
            <page-range>439-43</page-range>
            <pub-id pub-id-type="pmid">3346270</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moorefield</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>GR</given-names>
              </name>
            </person-group>
            <article-title>Aftermath of osteogenesis imperfecta: the disease in adulthood.</article-title>
            <source>J Bone Joint Surg Am</source>
            <year>1980</year>
            <month>Jan</month>
            <volume>62</volume>
            <issue>1</issue>
            <fpage>113</fpage>
            <page-range>113-9</page-range>
            <pub-id pub-id-type="pmid">7351402</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wenger</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Abrams</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Yaru</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Leach</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Obstruction of the colon due to protrusio acetabuli in osteogenesis imperfecta: treatment by pelvic osteotomy. Report of a case.</article-title>
            <source>J Bone Joint Surg Am</source>
            <year>1988</year>
            <month>Aug</month>
            <volume>70</volume>
            <issue>7</issue>
            <fpage>1103</fpage>
            <page-range>1103-7</page-range>
            <pub-id pub-id-type="pmid">3403582</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Renaud</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Aucourt</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Weill</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bigot</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dieux</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Devisme</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Moraux</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boutry</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Radiographic features of osteogenesis imperfecta.</article-title>
            <source>Insights Imaging</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>417</fpage>
            <page-range>417-29</page-range>
            <pub-id pub-id-type="pmid">23686748</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heimert</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Yousem</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Case 48: osteogenesis imperfecta of the temporal bone.</article-title>
            <source>Radiology</source>
            <year>2002</year>
            <month>Jul</month>
            <volume>224</volume>
            <issue>1</issue>
            <fpage>166</fpage>
            <page-range>166-70</page-range>
            <pub-id pub-id-type="pmid">12091678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Montpetit</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Palomo</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Glorieux</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Fassier</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rauch</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Multidisciplinary Treatment of Severe Osteogenesis Imperfecta: Functional Outcomes at Skeletal Maturity.</article-title>
            <source>Arch Phys Med Rehabil</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>96</volume>
            <issue>10</issue>
            <fpage>1834</fpage>
            <page-range>1834-9</page-range>
            <pub-id pub-id-type="pmid">26140741</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>TY</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Corrective osteotomy with retrograde Fassier-Duval nail in an osteogenesis imperfecta patient with bilateral genu valgum: A case report.</article-title>
            <source>Medicine (Baltimore)</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>96</volume>
            <issue>47</issue>
            <fpage>e8459</fpage>
            <pub-id pub-id-type="pmid">29381920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marom</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rabenhorst</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Morello</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Osteogenesis imperfecta: an update on clinical features and therapies.</article-title>
            <source>Eur J Endocrinol</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>183</volume>
            <issue>4</issue>
            <fpage>R95</fpage>
            <page-range>R95-R106</page-range>
            <pub-id pub-id-type="pmid">32621590</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rossi</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Marom</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Osteogenesis imperfecta: advancements in genetics and treatment.</article-title>
            <source>Curr Opin Pediatr</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>708</fpage>
            <page-range>708-715</page-range>
            <pub-id pub-id-type="pmid">31693577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aeschlimann</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Grunt</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Crigler</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Effects of sodium fluoride on the clinical course and metabolic balance of an infant with osteogenesis imperfecta congenita.</article-title>
            <source>Metabolism</source>
            <year>1966</year>
            <month>Oct</month>
            <volume>15</volume>
            <issue>10</issue>
            <fpage>905</fpage>
            <page-range>905-14</page-range>
            <pub-id pub-id-type="pmid">5923526</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castells</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Inamdar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Wallach</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Effects of porcine calcitonin in osteogenesis imperfecta tarda.</article-title>
            <source>J Pediatr</source>
            <year>1972</year>
            <month>May</month>
            <volume>80</volume>
            <issue>5</issue>
            <fpage>757</fpage>
            <page-range>757-62</page-range>
            <pub-id pub-id-type="pmid">5062955</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hamamoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kajiyama</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ono</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kihara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jinno</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Effect of long-term calcitonin therapy by injection and nasal spray on the incidence of fractures in osteogenesis imperfecta.</article-title>
            <source>J Pediatr</source>
            <year>1992</year>
            <month>Sep</month>
            <volume>121</volume>
            <issue>3</issue>
            <fpage>477</fpage>
            <page-range>477-80</page-range>
            <pub-id pub-id-type="pmid">1517930</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Low</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Loke</surname>
                <given-names>KY</given-names>
              </name>
            </person-group>
            <article-title>Cyclic pamidronate infusion improves bone mineralisation and reduces fracture incidence in osteogenesis imperfecta.</article-title>
            <source>Eur J Pediatr</source>
            <year>2001</year>
            <month>Nov</month>
            <volume>160</volume>
            <issue>11</issue>
            <fpage>641</fpage>
            <page-range>641-4</page-range>
            <pub-id pub-id-type="pmid">11760017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fujiwara</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ogawa</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Igarashi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ohba</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Asanuma</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Intravenous pamidronate treatment in osteogenesis imperfecta.</article-title>
            <source>Eur J Pediatr</source>
            <year>1998</year>
            <month>Mar</month>
            <volume>157</volume>
            <issue>3</issue>
            <fpage>261</fpage>
            <page-range>261-2</page-range>
            <pub-id pub-id-type="pmid">9537501</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gerber</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Binder</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Berry</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Weintrob</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Mizell</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marini</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Effects of withdrawal of bracing in matched pairs of children with osteogenesis imperfecta.</article-title>
            <source>Arch Phys Med Rehabil</source>
            <year>1998</year>
            <month>Jan</month>
            <volume>79</volume>
            <issue>1</issue>
            <fpage>46</fpage>
            <page-range>46-51</page-range>
            <pub-id pub-id-type="pmid">9440417</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gerber</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Binder</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Weintrob</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Grange</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Shapiro</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fromherz</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Berry</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Conway</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nason</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marini</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Rehabilitation of children and infants with osteogenesis imperfecta. A program for ambulation.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>1990</year>
            <month>Feb</month>
            <issue>251</issue>
            <fpage>254</fpage>
            <page-range>254-62</page-range>
            <pub-id pub-id-type="pmid">2295183</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bains</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Citron</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Boskey</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Shapiro</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Steiner</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Bober</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cuthbertson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Krischer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Byers</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Pepin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Durigova</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Glorieux</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Rauch</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sliepka</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Sutton</surname>
                <given-names>VR</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>B</given-names>
              </name>
              <collab>Members of the BBD Consortium</collab>
              <name>
                <surname>Nagamani</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Raggio</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>A Multicenter Observational Cohort Study to Evaluate the Effects of Bisphosphonate Exposure on Bone Mineral Density and Other Health Outcomes in Osteogenesis Imperfecta.</article-title>
            <source>JBMR Plus</source>
            <year>2019</year>
            <month>May</month>
            <volume>3</volume>
            <issue>5</issue>
            <fpage>e10118</fpage>
            <pub-id pub-id-type="pmid">31131341</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hald</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Evangelou</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Langdahl</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Ralston</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Bisphosphonates for the prevention of fractures in osteogenesis imperfecta: meta-analysis of placebo-controlled trials.</article-title>
            <source>J Bone Miner Res</source>
            <year>2015</year>
            <month>May</month>
            <volume>30</volume>
            <issue>5</issue>
            <fpage>929</fpage>
            <page-range>929-33</page-range>
            <pub-id pub-id-type="pmid">25407702</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dwan</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Phillipi</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Steiner</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Basel</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Bisphosphonate therapy for osteogenesis imperfecta.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2016</year>
            <month>Oct</month>
            <day>19</day>
            <volume>10</volume>
            <issue>10</issue>
            <fpage>CD005088</fpage>
            <pub-id pub-id-type="pmid">27760454</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jovanovic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guterman-Ram</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Marini</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Classical and Rare OI Types.</article-title>
            <source>Endocr Rev</source>
            <year>2022</year>
            <month>Jan</month>
            <day>12</day>
            <volume>43</volume>
            <issue>1</issue>
            <fpage>61</fpage>
            <page-range>61-90</page-range>
            <pub-id pub-id-type="pmid">34007986</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guillot</surname>
                <given-names>PV</given-names>
              </name>
              <name>
                <surname>Abass</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Bassett</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Shefelbine</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Bou-Gharios</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kurata</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Polak</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fisk</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice.</article-title>
            <source>Blood</source>
            <year>2008</year>
            <month>Feb</month>
            <day>01</day>
            <volume>111</volume>
            <issue>3</issue>
            <fpage>1717</fpage>
            <page-range>1717-25</page-range>
            <pub-id pub-id-type="pmid">17967940</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Panaroni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gioia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lupi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Besio</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Kreider</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Leikin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vera</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Mertz</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Perilli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Baruffaldi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Villa</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Farina</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Casasco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cetta</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rossi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Frattini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marini</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Vezzoni</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Forlino</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta.</article-title>
            <source>Blood</source>
            <year>2009</year>
            <month>Jul</month>
            <day>09</day>
            <volume>114</volume>
            <issue>2</issue>
            <fpage>459</fpage>
            <page-range>459-68</page-range>
            <pub-id pub-id-type="pmid">19414862</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sinder</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Novak</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wee</surname>
                <given-names>NKY</given-names>
              </name>
              <name>
                <surname>Basile</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maye</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Matthews</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Kalajzic</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Engraftment of skeletal progenitor cells by bone-directed transplantation improves osteogenesis imperfecta murine bone phenotype.</article-title>
            <source>Stem Cells</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>38</volume>
            <issue>4</issue>
            <fpage>530</fpage>
            <page-range>530-541</page-range>
            <pub-id pub-id-type="pmid">31859429</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sinder</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Eddy</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Ominsky</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Caird</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Marini</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Kozloff</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Sclerostin antibody improves skeletal parameters in a Brtl/+ mouse model of osteogenesis imperfecta.</article-title>
            <source>J Bone Miner Res</source>
            <year>2013</year>
            <month>Jan</month>
            <volume>28</volume>
            <issue>1</issue>
            <fpage>73</fpage>
            <page-range>73-80</page-range>
            <pub-id pub-id-type="pmid">22836659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grafe</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Alexander</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lietman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Homan</surname>
                <given-names>EP</given-names>
              </name>
              <name>
                <surname>Munivez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Bertin</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dawson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Asuncion</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ke</surname>
                <given-names>HZ</given-names>
              </name>
              <name>
                <surname>Ominsky</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Sclerostin Antibody Treatment Improves the Bone Phenotype of Crtap(-/-) Mice, a Model of Recessive Osteogenesis Imperfecta.</article-title>
            <source>J Bone Miner Res</source>
            <year>2016</year>
            <month>May</month>
            <volume>31</volume>
            <issue>5</issue>
            <fpage>1030</fpage>
            <page-range>1030-40</page-range>
            <pub-id pub-id-type="pmid">26716893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perosky</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Khoury</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Jenks</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Cortright</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Barton</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Sinder</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Marini</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Caird</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Kozloff</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Single dose of bisphosphonate preserves gains in bone mass following cessation of sclerostin antibody in Brtl/+ osteogenesis imperfecta model.</article-title>
            <source>Bone</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>93</volume>
            <fpage>79</fpage>
            <page-range>79-85</page-range>
            <pub-id pub-id-type="pmid">27641475</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Little</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Peacock</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mikulec</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kneissel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kramer</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Schindeler</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Munns</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfecta.</article-title>
            <source>Bone</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>101</volume>
            <fpage>96</fpage>
            <page-range>96-103</page-range>
            <pub-id pub-id-type="pmid">28461254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoyer-Kuhn</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Netzer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Koerber</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Schoenau</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Semler</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Two years' experience with denosumab for children with osteogenesis imperfecta type VI.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2014</year>
            <month>Sep</month>
            <day>26</day>
            <volume>9</volume>
            <fpage>145</fpage>
            <pub-id pub-id-type="pmid">25257953</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Orwoll</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Shapiro</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Veith</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lapidus</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vanek</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Reeder</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Keaveny</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Mullins</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Nagamani</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of teriparatide treatment in adults with osteogenesis imperfecta.</article-title>
            <source>J Clin Invest</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>124</volume>
            <issue>2</issue>
            <fpage>491</fpage>
            <page-range>491-8</page-range>
            <pub-id pub-id-type="pmid">24463451</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tauer</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Abdullah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rauch</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Effect of Anti-TGF-&#x003b2; Treatment in a Mouse Model of Severe Osteogenesis Imperfecta.</article-title>
            <source>J Bone Miner Res</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>207</fpage>
            <page-range>207-214</page-range>
            <pub-id pub-id-type="pmid">30357929</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tauer</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Rauch</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Osteogenesis Imperfecta: New Perspectives From Clinical and Translational Research.</article-title>
            <source>JBMR Plus</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>3</volume>
            <issue>8</issue>
            <fpage>e10174</fpage>
            <pub-id pub-id-type="pmid">31485550</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Houghton</surname>
                <given-names>GR</given-names>
              </name>
            </person-group>
            <article-title>Pneumatic trouser splints in the treatment of severe osteogenesis imperfecta.</article-title>
            <source>Acta Orthop Scand</source>
            <year>1982</year>
            <month>Aug</month>
            <volume>53</volume>
            <issue>4</issue>
            <fpage>547</fpage>
            <page-range>547-52</page-range>
            <pub-id pub-id-type="pmid">7102270</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frost</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Middleton</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Hillier</surname>
                <given-names>LG</given-names>
              </name>
            </person-group>
            <article-title>A stereotaxic device for the closed exchange of intramedullary rods, using image-intensified X-rays, in children with osteogenesis imperfecta.</article-title>
            <source>Eng Med</source>
            <year>1986</year>
            <month>Jul</month>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>131</fpage>
            <page-range>131-5</page-range>
            <pub-id pub-id-type="pmid">3527804</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ry&#x000f6;ppy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Alberty</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kaitila</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Early semiclosed intramedullary stabilization in osteogenesis imperfecta.</article-title>
            <source>J Pediatr Orthop</source>
            <year>1987</year>
            <season>Mar-Apr</season>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>139</fpage>
            <page-range>139-44</page-range>
            <pub-id pub-id-type="pmid">3558793</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sijbrandij</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Percutaneous nailing in the management of osteogenesis imperfecta.</article-title>
            <source>Int Orthop</source>
            <year>1990</year>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>195</fpage>
            <page-range>195-7</page-range>
            <pub-id pub-id-type="pmid">2373568</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Swischuk</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Hayden</surname>
                <given-names>CK</given-names>
              </name>
            </person-group>
            <article-title>Rickets: a roentgenographic scheme for diagnosis.</article-title>
            <source>Pediatr Radiol</source>
            <year>1979</year>
            <month>Oct</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>203</fpage>
            <page-range>203-8</page-range>
            <pub-id pub-id-type="pmid">514674</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marlowe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pepin</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Byers</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>Testing for osteogenesis imperfecta in cases of suspected non-accidental injury.</article-title>
            <source>J Med Genet</source>
            <year>2002</year>
            <month>Jun</month>
            <volume>39</volume>
            <issue>6</issue>
            <fpage>382</fpage>
            <page-range>382-6</page-range>
            <pub-id pub-id-type="pmid">12070242</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Engelbert</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Uiterwaal</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Gulmans</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Pruijs</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Helders</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Osteogenesis imperfecta in childhood: prognosis for walking.</article-title>
            <source>J Pediatr</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>137</volume>
            <issue>3</issue>
            <fpage>397</fpage>
            <page-range>397-402</page-range>
            <pub-id pub-id-type="pmid">10969267</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mrosk</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bhavani</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hecht</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kr&#x000fc;ger</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Shukla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kornak</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Girisha</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic strategies and genotype-phenotype correlation in a large Indian cohort of osteogenesis imperfecta.</article-title>
            <source>Bone</source>
            <year>2018</year>
            <month>May</month>
            <volume>110</volume>
            <fpage>368</fpage>
            <page-range>368-377</page-range>
            <pub-id pub-id-type="pmid">29499418</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheung</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Glorieux</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Rauch</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Natural history of hyperplastic callus formation in osteogenesis imperfecta type V.</article-title>
            <source>J Bone Miner Res</source>
            <year>2007</year>
            <month>Aug</month>
            <volume>22</volume>
            <issue>8</issue>
            <fpage>1181</fpage>
            <page-range>1181-6</page-range>
            <pub-id pub-id-type="pmid">17451374</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takahashi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Okada</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nagasawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shimada</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sakamoto</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Itoi</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Osteosarcoma occurring in osteogenesis imperfecta.</article-title>
            <source>Virchows Arch</source>
            <year>2004</year>
            <month>May</month>
            <volume>444</volume>
            <issue>5</issue>
            <fpage>454</fpage>
            <page-range>454-8</page-range>
            <pub-id pub-id-type="pmid">15214333</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r75">
          <label>75</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Engelbert</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Gerver</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Breslau-Siderius</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>van der Graaf</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Pruijs</surname>
                <given-names>HE</given-names>
              </name>
              <name>
                <surname>van Doorne</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Beemer</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Helders</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Spinal complications in osteogenesis imperfecta: 47 patients 1-16 years of age.</article-title>
            <source>Acta Orthop Scand</source>
            <year>1998</year>
            <month>Jun</month>
            <volume>69</volume>
            <issue>3</issue>
            <fpage>283</fpage>
            <page-range>283-6</page-range>
            <pub-id pub-id-type="pmid">9703404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26388.r76">
          <label>76</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paterson</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Ogston</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Life expectancy in osteogenesis imperfecta.</article-title>
            <source>BMJ</source>
            <year>1996</year>
            <month>Feb</month>
            <day>10</day>
            <volume>312</volume>
            <issue>7027</issue>
            <fpage>351</fpage>
            <pub-id pub-id-type="pmid">8611834</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
